Firmenintern

Gerresheimer establishes small series production in the USA

Pharma and medical technology specialist Gerresheimer has established small series production at its Technical Competence Center at its Peachtree City, Georgia location. Small quantities of products can now be manufactured under series conditions and in ISO class 8 cleanroom. During the development and approval of pharmaceutical products and medical devices, this kind of small series is regularly needed for clinical samples or stability batches.

Prior to series production, pharmaceutical products and medical devices run through an exhaustive approval process for which small numbers of units need to be produced repeatedly, for examples, as clinical samples, development samples or stability batches. In 2013, Gerresheimer opened its own small series production at its Technical Competence Center in Wackersdorf, Germany, to accomplish this task. The company is now continuing this success story, starting small series production at its Peachtree City production location to be able to offer American customers small series production locally.

Besides providing small volumes of product, small series production also enables Gerresheimer to optimize the production process in the pilot phase. All the expertise required for series production can be established, while processes can be developed and streamlined. The experience gained during mold making and automation can be harnessed to design series molds and series equipment.

Setup of small series production began at the Technical Competence Center at the Peachtree City location in 2020 with the conversion of an existing building as well as setup of an ISO class 8 cleanroom in accordance with DIN EN ISO 14644-1. Small series production then took up operation in 2021. “The equipment in small series production adapts to the project. We are currently producing an innovative product for ophthalmology, an innovative point-of-care test system and a combination product in accordance with the FDA definition,” explains Manfred Baumann (Global Executive VP Sales & Marketing, Administration & TCC, Gerresheimer Regensburg GmbH).  Based on these projects, the equipment in small series production currently includes an injection molding machine with a clamping force of 120 tons that connects with handling systems and parts conveyors. Project-specific assembly and packaging units such as granulation, fill & seal plants as well as manual assembly stations, including ultrasonic welding systems, are also available. For quality assurance, small series production has its own fully equipped measurement laboratory with product-specific testing equipment with optical and tactile measuring machines and other testing equipment.

Über die Gerresheimer AG

Gerresheimer is a leading international partner of the pharmaceuticals and health care industries. The company contributes to health and well-being with special products of glass and plastic. Gerresheimer is represented worldwide and, with around 10,000 employees, produces where our customers and markets are. With works in Europe, North and South America, and Asia, Gerresheimer achieves a turnover of around 1.4 billion Euro. The broad range of the offering encompasses pharmaceutical packaging, as well as products for the simple and secure administering of medications: insulin pens, inhalers, pre-fillable syringes, injection vials, ampules, bottles, and containers for liquid and solid medications with sealing and safety systems, as well as packaging for the cosmetics industry.

Firmenkontakt und Herausgeber der Meldung:

Gerresheimer AG
Klaus-Bungert-Straße 4
40468 Düsseldorf
Telefon: +49 (211) 6181-00
Telefax: +49 (211) 6181-295
http://www.gerresheimer.de

Ansprechpartner:
Karin Fischer
Communication & Marketing Medical Plastic Systems
Telefon: +49 (9431) 639-6140
Fax: +49 (9431) 79838-6140
E-Mail: k.fischer@gerresheimer.com
Marion Stolzenwald
Senior Manager Group Communication
Telefon: +49 (211) 6181-246
Fax: +49 (211) 6181-241
E-Mail: m.stolzenwald@gerresheimer.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel